Lam Research Co. (NASDAQ:LRCX) Shares Sold by Yousif Capital Management LLC

Yousif Capital Management LLC cut its stake in Lam Research Co. (NASDAQ:LRCX) by 8.6% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 19,392 shares of the semiconductor company’s stock after selling 1,823 shares during the quarter. Yousif Capital Management LLC’s holdings in Lam Research were worth $15,189,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently modified their holdings of LRCX. Orion Capital Management LLC purchased a new stake in shares of Lam Research in the third quarter valued at about $25,000. BluePath Capital Management LLC purchased a new stake in Lam Research in the 3rd quarter valued at approximately $28,000. OFI Invest Asset Management acquired a new stake in Lam Research during the 3rd quarter valued at $30,000. Asset Dedication LLC increased its position in Lam Research by 56.7% during the third quarter. Asset Dedication LLC now owns 47 shares of the semiconductor company’s stock worth $30,000 after buying an additional 17 shares in the last quarter. Finally, Valued Wealth Advisors LLC acquired a new position in shares of Lam Research in the fourth quarter worth $30,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Lam Research

In related news, SVP Seshasayee Varadarajan sold 5,500 shares of the firm’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $922.41, for a total transaction of $5,073,255.00. Following the sale, the senior vice president now directly owns 22,095 shares in the company, valued at approximately $20,380,648.95. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CAO Christina Corrreia sold 647 shares of the firm’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $972.03, for a total transaction of $628,903.41. Following the completion of the sale, the chief accounting officer now directly owns 5,541 shares in the company, valued at $5,386,018.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Seshasayee Varadarajan sold 5,500 shares of the business’s stock in a transaction dated Monday, March 18th. The stock was sold at an average price of $922.41, for a total value of $5,073,255.00. Following the completion of the transaction, the senior vice president now owns 22,095 shares in the company, valued at approximately $20,380,648.95. The disclosure for this sale can be found here. Insiders sold 7,029 shares of company stock valued at $6,559,489 over the last quarter. Company insiders own 0.32% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Barclays lifted their price objective on Lam Research from $750.00 to $825.00 and gave the stock an “equal weight” rating in a research report on Thursday, January 25th. Stifel Nicolaus lifted their price target on shares of Lam Research from $950.00 to $1,050.00 and gave the stock a “buy” rating in a report on Tuesday, April 16th. Raymond James upped their price objective on shares of Lam Research from $850.00 to $950.00 and gave the company an “outperform” rating in a research note on Thursday, January 25th. Needham & Company LLC lifted their target price on shares of Lam Research from $900.00 to $1,030.00 and gave the stock a “buy” rating in a research note on Thursday, April 18th. Finally, Mizuho increased their price target on Lam Research from $900.00 to $935.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. Seven investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $931.85.

Lam Research Trading Up 0.5 %

NASDAQ LRCX traded up $4.09 during mid-day trading on Wednesday, hitting $891.51. The company’s stock had a trading volume of 1,170,053 shares, compared to its average volume of 1,057,238. The company has a debt-to-equity ratio of 0.61, a current ratio of 3.06 and a quick ratio of 2.02. Lam Research Co. has a 52-week low of $493.42 and a 52-week high of $1,007.39. The stock’s fifty day simple moving average is $944.54 and its two-hundred day simple moving average is $805.82. The firm has a market capitalization of $116.88 billion, a P/E ratio of 34.32, a price-to-earnings-growth ratio of 3.14 and a beta of 1.51.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share for the quarter, beating the consensus estimate of $7.06 by $0.46. Lam Research had a net margin of 24.15% and a return on equity of 44.47%. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.71 billion. During the same quarter in the previous year, the business posted $10.71 EPS. The business’s quarterly revenue was down 28.8% on a year-over-year basis. Research analysts expect that Lam Research Co. will post 28.92 EPS for the current year.

Lam Research Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, April 3rd. Shareholders of record on Wednesday, March 13th were paid a dividend of $2.00 per share. This represents a $8.00 dividend on an annualized basis and a dividend yield of 0.90%. The ex-dividend date was Tuesday, March 12th. Lam Research’s dividend payout ratio is presently 30.94%.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.